首页> 外国专利> CONCOMITATING USE OF THE INSULIN-SIMILAR GROWTH FACTOR -I (IN THE FOLLOWING 'FCI-I') AND THE BETA TRANSFORMING GROWTH FACTOR (IN THE 'FCT-BETA' SUCCESSIVE) FOR THE MANUFACTURE OF A BONE REGENERATION MEDICATION Mammals

CONCOMITATING USE OF THE INSULIN-SIMILAR GROWTH FACTOR -I (IN THE FOLLOWING 'FCI-I') AND THE BETA TRANSFORMING GROWTH FACTOR (IN THE 'FCT-BETA' SUCCESSIVE) FOR THE MANUFACTURE OF A BONE REGENERATION MEDICATION Mammals

机译:胰岛素类似生长因子-I(在“ FCI-I”之后)和BETA转化生长因子(在“ FCT-BETA”连续)中的使用同时用于骨再生药物哺乳动物的制造

摘要

THE CURE OF AN EXTERNAL INJURY AND / OR OSEA REGENERATION OF A MAMIFERO ADMINISTRANDOLE A COMPOSITION CONTAINING BETA FACTOR OF PURIFIED TRANSFORMATION GROWTH AND FACTOR-I OF THE PURIFIED GROWTH LIKE INSULIN OR FACTOR-II OF THE INSTITUTE GROWTH.
机译:含变形转化生长因子和纯化后的生长因子-I(如胰岛素)或研究所生长因子-II的组成成分的金刚烷胺的外伤和/或OSEA再生的治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号